Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jan 24;81(3):235-236.
doi: 10.1016/j.jacc.2022.11.014.

PCSK9: The Nexus of Lipoprotein Metabolism and Inflammation in COVID-19

Sascha N Goonewardena  1 , Robert S Rosenson  2
Affiliations
Editorial

PCSK9: The Nexus of Lipoprotein Metabolism and Inflammation in COVID-19

Sascha N Goonewardena et al. J Am Coll Cardiol. .
No abstract available

Keywords: COVID-19; PCSK9; inflammation; lipoprotein.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Rosenson receives research funding to his institution from Amgen, Arrowhead, Eli Lilly, Novartis, and Regeneron; has received consulting fees from Amgen, Arrowhead, CRISPR Therapeutics, Eli Lilly, Lipigon, Novartis, Precision Biosciences, Regeneron, Ultrgenyx, and Verve; has received nonpromotional speaking fees from Amgen, Kowa, and Regeneron; has received royalties from Wolters Kluwer (UpToDate); and has stock holdings in MediMergent. Dr Goonewardena has reported that he has no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection.
    Navarese EP, Podhajski P, Gurbel PA, Grzelakowska K, Ruscio E, Tantry U, Magielski P, Kubica A, Niezgoda P, Adamski P, Junik R, Przybylski G, Pilaczyńska-Cemel M, Rupji M, Specchia G, Pinkas J, Gajda R, Gorog DA, Andreotti F, Kubica J. Navarese EP, et al. J Am Coll Cardiol. 2023 Jan 24;81(3):224-234. doi: 10.1016/j.jacc.2022.10.030. J Am Coll Cardiol. 2023. PMID: 36653090 Free PMC article. Clinical Trial.

References

    1. Choi D., Chen Q., Goonewardena S.N., et al. Efficacy of statin therapy in patients with hospital admission for COVID-19. Cardiovasc Drugs Ther. 2022;36:1165–1173. - PMC - PubMed
    1. Zhang X.J., Qin J.J., Cheng X., et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. 2020;32:176–187.e4. - PMC - PubMed
    1. Talasaz A.H., Sadeghipour P., Aghakouchakzadeh M., et al. Investigating lipid-modulating agents for prevention or treatment of COVID-19: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78:1635–1654. - PMC - PubMed
    1. Horton J.D., Cohen J.C., Hobbs H.H. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res. 2009;50(suppl):S172–177. - PMC - PubMed
    1. Lakoski S.G., Lagace T.A., Cohen J.C., Horton J.D., Hobbs H.H. Genetic and metabolic determinants of plasma PCSK9 levels. J Clin Endocrinol Metab. 2009;94:2537–2543. - PMC - PubMed